Skip to content
Clever Leaves
  • HOME
  • WHY CLEVER LEAVES
    • ABOUT US
    • OUR LEADERSHIP TEAM
    • OUR BOARD OF DIRECTORS
    • OUR MISSION
    • OUR VALUES
  • WHAT WE DO
    • B2B
    • US CONSUMER BRAND
    • STRATEGIC INVESTMENTS
  • INVESTORS
  • CLEVER LEAVES IN THE NEWS
  • CONTACT US
  • EnglishEnglish
  • EspañolEspañol
Clever Leaves

Month: February 2022

The Australian Natural Therapeutics Group Signs a US$7.8M Product Agreement With Clever Leaves to Accelerate Medical Cannabis Access in Australia

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market

Clever Leaves Expands Partnership With Cansativa; Cansativa Raises Up to $15 Million in Financing Led by Casa Verde

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market

Clever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis market
Clever leaves background

Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership

Products imported and to be commercially available in German pharmacies

Products imported and to be commercially available in German pharmacies

Clever Leaves Holdings Inc. beginnt mit dem Verkauf von Cannabisextrakten in Deutschland durch eine Partnerschaft mit Ethypharm

Produkte sind bald in deutschen Apotheken erhältlich

Produkte sind bald in deutschen Apotheken erhältlich

Clever Leaves Expands Relationship With Cannatrek in Australia With a Two-Year $3.6M Sales Agreement

The agreement will now include high-THC Flower from Portugal facilities and will allow for the expansion of its oral solution supply

The agreement will now include high-THC Flower from Portugal facilities and will allow for the expansion of its oral solution supply
Clever leaves banner

Clever Leaves Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 Outlook

Performance Delivers on 2021 Outlook and Provides Solid Foundation for 2022

Clever Leaves Announces Leadership Transition Plan

Kyle Detwiler to Step Down as CEO; Andres Fajardo to be Appointed CEO

Kyle Detwiler to Step Down as CEO; Andres Fajardo to be Appointed CEO

Clever Leaves Appoints George Schultze to Board of Directors

Appointment Accompanied by One-Year Lock-Up for Schultze Special Purpose Acquisition Sponsor Shares

Appointment Accompanied by One-Year Lock-Up for Schultze Special Purpose Acquisition Sponsor Shares

Recent Posts

  • Clever Leaves Announces Wind-Down of Portugal Operations as Part of Ongoing Restructuring Initiatives
  • Clever Leaves Reports Third Quarter 2022 Results
  • Portuguese Health Authority Grants Clever Leaves EU-GMP Certification for Post-Harvest Cannabis Flower
  • Clever Leaves Partners with Anden Naturals to Bring Pharmaceutical-Grade Cannabis to Patients in Peru
  • Clever Leaves to Hold Third Quarter 2022 Conference Call on Wednesday, November 9, 2022 at 5:00 p.m. ET

Recent Comments

    Archives

    • January 2023
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • August 2021
    • July 2021
    • June 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • May 2019
    • March 2019
    • February 2019
    • June 2018

    Categories

    • blog
    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org